BamSEC and AlphaSense Join Forces
Learn More

Corcept Therapeutics Incorporated

NASDAQ: CORT    
Share price (12/24/24): $52.17    
Market cap (12/24/24): $5.466 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.4
from S-8 5 pages Corcept Therapeutics, Incorporated 2024 Incentive Award Plan Restricted Stock Award Grant Notice
12/34/56
EX-4.3
from S-8 9 pages Corcept Therapeutics Incorporated 2024 Incentive Award Plan Stock Option Grant Notice
12/34/56
EX-4.5
from S-8 7 pages To Stock Option Grant Notice Corcept Therapeutics Incorporated Stock Option Agreement
12/34/56
EX-4.2
from 10-K 3 pages Description of Common Stock
12/34/56
EX-4.2
from 10-K 4 pages Description of Common Stock
12/34/56
EX-4.5
from S-8 10 pages Corcept Therapeutics Incorporated 2012 Incentive Award Plan Stock Option Grant Notice
12/34/56
EX-4.4
from S-3 52 pages Corcept Therapeutics Incorporated Indenture Dated as of , 20 Wilmington Trust, National Association Trustee
12/34/56
EX-4.4
from S-3 51 pages Corcept Therapeutics Incorporated Indenture Dated as of , 20 Wilmington Trust, National Association as Trustee
12/34/56
EX-4.5
from S-8 10 pages Corcept Therapeutics Incorporated 2012 Incentive Award Plan Stock Option Grant Notice
12/34/56
EX-4.2
from 8-K 22 pages Registration Rights Agreement
12/34/56
EX-4.1
from 8-K 10 pages Form of Warrant
12/34/56
EX-4.4
from S-3 41 pages Form of Corcept Therapeutics Incorporated Indenture Dated as of [Name of Trustee] Trustee
12/34/56
EX-4.3
from S-3 40 pages Form of Corcept Therapeutics Incorporated Indenture Dated as of [Name of Trustee] Trustee
12/34/56
EX-4.2
from 8-K 22 pages Registration Rights Agreement
12/34/56
EX-4.1
from 8-K 10 pages Form of Warrant
12/34/56
EX-4.2
from 10-Q 22 pages Registration Rights Agreement
12/34/56
EX-4.1
from 10-Q 9 pages Warrant to Purchase Shares of Common Stock of Corcept Therapeutics Incorporated
12/34/56
EX-4.1
from S-8 17 pages Amended and Restated 2004 Equity Incentive Plan of Corcept Therapeutics Incorporated
12/34/56
EX-4.5
from 10-K 13 pages The Securities Evidenced by This Warrant Have Not Been Registered Under the U.S. Securities Act of 1933, as Amended (The “Securities Act”), or Any Other Applicable Securities Laws and Have Been Issued in Reliance Upon an Exemption From the Registration Requirements of the Securities Act and Such Other Securities Laws. Neither This Security Nor Any Interest or Participation Herein May Be Reoffered, Sold, Assigned, Transferred, Pledged, Encumbered, Hypothecated or Otherwise Disposed Of, Except Pursuant to an Effective Registration Statement Under the Securities Act or Pursuant to a Transaction Which Is Exempt From, or Not Subject To, Such Registration
12/34/56
EX-4.4
from 10-K 10 pages Warrant to Purchase Shares of Common Stock of Corcept Therapeutics Incorporated
12/34/56